2021-2027 Global and Regional Pressurized Metered Dose Inhaler Industry Status and Prospects Professional Market Research Report Standard Version
Date: Aug-2021 | Id: MACRC-71647 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Pressurized Metered Dose Inhaler market was valued at 5406.26 Million USD in 2020 and will grow with a CAGR of 3.61% from 2020 to 2027, based on HNY Research newly published report. <br>The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). <br>A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future. Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%. North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%. Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. <br>By Market Verdors: <br>GlaxoSmithKline <br>Chiesi Farmaceutici S.p.A <br>AstraZeneca <br>Teva <br>Merck & Co. Inc <br>Boehringer Ingelheim <br>Mylan <br>Arkon <br> <br>By Types: <br>Manual Pressurized Metered Dose Inhaler <br>Smart Pressurized Metered Dose Inhaler <br> <br>By Applications: <br>Asthma <br>COPD <br> <br>Key Indicators Analysed <br>Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. <br>Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. <br>Market Trends: Market key trends which include Increased Competition and Continuous Innovations. <br>Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology <br>Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. <br> <br>Key Reasons to Purchase <br>To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. <br>Assess the production processes, major issues, and solutions to mitigate the development risk. <br>To understand the most affecting driving and restraining forces in the market and its impact in the global market. <br>Learn about the market strategies that are being adopted by leading respective organizations. <br>To understand the future outlook and prospects for the market. <br>Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Pressurized Metered Dose Inhaler Market Size Analysis from 2022 to 2027
1.5.1 Global Pressurized Metered Dose Inhaler Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Pressurized Metered Dose Inhaler Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Pressurized Metered Dose Inhaler Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Pressurized Metered Dose Inhaler Industry Impact
Chapter 2 Global Pressurized Metered Dose Inhaler Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pressurized Metered Dose Inhaler (Volume and Value) by Type
2.1.1 Global Pressurized Metered Dose Inhaler Consumption and Market Share by Type (2016-2021)
2.1.2 Global Pressurized Metered Dose Inhaler Revenue and Market Share by Type (2016-2021)
2.2 Global Pressurized Metered Dose Inhaler (Volume and Value) by Application
2.2.1 Global Pressurized Metered Dose Inhaler Consumption and Market Share by Application (2016-2021)
2.2.2 Global Pressurized Metered Dose Inhaler Revenue and Market Share by Application (2016-2021)
2.3 Global Pressurized Metered Dose Inhaler (Volume and Value) by Regions
2.3.1 Global Pressurized Metered Dose Inhaler Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Pressurized Metered Dose Inhaler Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Pressurized Metered Dose Inhaler Consumption by Regions (2016-2021)
4.2 North America Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
4.10 South America Pressurized Metered Dose Inhaler Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Pressurized Metered Dose Inhaler Market Analysis
5.1 North America Pressurized Metered Dose Inhaler Consumption and Value Analysis
5.1.1 North America Pressurized Metered Dose Inhaler Market Under COVID-19
5.2 North America Pressurized Metered Dose Inhaler Consumption Volume by Types
5.3 North America Pressurized Metered Dose Inhaler Consumption Structure by Application
5.4 North America Pressurized Metered Dose Inhaler Consumption by Top Countries
5.4.1 United States Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
5.4.2 Canada Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
5.4.3 Mexico Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 6 East Asia Pressurized Metered Dose Inhaler Market Analysis
6.1 East Asia Pressurized Metered Dose Inhaler Consumption and Value Analysis
6.1.1 East Asia Pressurized Metered Dose Inhaler Market Under COVID-19
6.2 East Asia Pressurized Metered Dose Inhaler Consumption Volume by Types
6.3 East Asia Pressurized Metered Dose Inhaler Consumption Structure by Application
6.4 East Asia Pressurized Metered Dose Inhaler Consumption by Top Countries
6.4.1 China Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
6.4.2 Japan Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
6.4.3 South Korea Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 7 Europe Pressurized Metered Dose Inhaler Market Analysis
7.1 Europe Pressurized Metered Dose Inhaler Consumption and Value Analysis
7.1.1 Europe Pressurized Metered Dose Inhaler Market Under COVID-19
7.2 Europe Pressurized Metered Dose Inhaler Consumption Volume by Types
7.3 Europe Pressurized Metered Dose Inhaler Consumption Structure by Application
7.4 Europe Pressurized Metered Dose Inhaler Consumption by Top Countries
7.4.1 Germany Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.2 UK Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.3 France Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.4 Italy Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.5 Russia Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.6 Spain Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.7 Netherlands Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.8 Switzerland Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
7.4.9 Poland Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 8 South Asia Pressurized Metered Dose Inhaler Market Analysis
8.1 South Asia Pressurized Metered Dose Inhaler Consumption and Value Analysis
8.1.1 South Asia Pressurized Metered Dose Inhaler Market Under COVID-19
8.2 South Asia Pressurized Metered Dose Inhaler Consumption Volume by Types
8.3 South Asia Pressurized Metered Dose Inhaler Consumption Structure by Application
8.4 South Asia Pressurized Metered Dose Inhaler Consumption by Top Countries
8.4.1 India Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
8.4.2 Pakistan Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Pressurized Metered Dose Inhaler Market Analysis
9.1 Southeast Asia Pressurized Metered Dose Inhaler Consumption and Value Analysis
9.1.1 Southeast Asia Pressurized Metered Dose Inhaler Market Under COVID-19
9.2 Southeast Asia Pressurized Metered Dose Inhaler Consumption Volume by Types
9.3 Southeast Asia Pressurized Metered Dose Inhaler Consumption Structure by Application
9.4 Southeast Asia Pressurized Metered Dose Inhaler Consumption by Top Countries
9.4.1 Indonesia Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
9.4.2 Thailand Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
9.4.3 Singapore Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
9.4.4 Malaysia Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
9.4.5 Philippines Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
9.4.6 Vietnam Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
9.4.7 Myanmar Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 10 Middle East Pressurized Metered Dose Inhaler Market Analysis
10.1 Middle East Pressurized Metered Dose Inhaler Consumption and Value Analysis
10.1.1 Middle East Pressurized Metered Dose Inhaler Market Under COVID-19
10.2 Middle East Pressurized Metered Dose Inhaler Consumption Volume by Types
10.3 Middle East Pressurized Metered Dose Inhaler Consumption Structure by Application
10.4 Middle East Pressurized Metered Dose Inhaler Consumption by Top Countries
10.4.1 Turkey Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.3 Iran Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.5 Israel Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.6 Iraq Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.7 Qatar Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.8 Kuwait Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
10.4.9 Oman Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 11 Africa Pressurized Metered Dose Inhaler Market Analysis
11.1 Africa Pressurized Metered Dose Inhaler Consumption and Value Analysis
11.1.1 Africa Pressurized Metered Dose Inhaler Market Under COVID-19
11.2 Africa Pressurized Metered Dose Inhaler Consumption Volume by Types
11.3 Africa Pressurized Metered Dose Inhaler Consumption Structure by Application
11.4 Africa Pressurized Metered Dose Inhaler Consumption by Top Countries
11.4.1 Nigeria Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
11.4.2 South Africa Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
11.4.3 Egypt Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
11.4.4 Algeria Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
11.4.5 Morocco Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 12 Oceania Pressurized Metered Dose Inhaler Market Analysis
12.1 Oceania Pressurized Metered Dose Inhaler Consumption and Value Analysis
12.2 Oceania Pressurized Metered Dose Inhaler Consumption Volume by Types
12.3 Oceania Pressurized Metered Dose Inhaler Consumption Structure by Application
12.4 Oceania Pressurized Metered Dose Inhaler Consumption by Top Countries
12.4.1 Australia Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
12.4.2 New Zealand Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 13 South America Pressurized Metered Dose Inhaler Market Analysis
13.1 South America Pressurized Metered Dose Inhaler Consumption and Value Analysis
13.1.1 South America Pressurized Metered Dose Inhaler Market Under COVID-19
13.2 South America Pressurized Metered Dose Inhaler Consumption Volume by Types
13.3 South America Pressurized Metered Dose Inhaler Consumption Structure by Application
13.4 South America Pressurized Metered Dose Inhaler Consumption Volume by Major Countries
13.4.1 Brazil Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
13.4.2 Argentina Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
13.4.3 Columbia Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
13.4.4 Chile Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
13.4.5 Venezuela Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
13.4.6 Peru Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
13.4.8 Ecuador Pressurized Metered Dose Inhaler Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Pressurized Metered Dose Inhaler Business
14.1 GlaxoSmithKline
14.1.1 GlaxoSmithKline Company Profile
14.1.2 GlaxoSmithKline Pressurized Metered Dose Inhaler Product Specification
14.1.3 GlaxoSmithKline Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Chiesi Farmaceutici S.p.A
14.2.1 Chiesi Farmaceutici S.p.A Company Profile
14.2.2 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product Specification
14.2.3 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 AstraZeneca
14.3.1 AstraZeneca Company Profile
14.3.2 AstraZeneca Pressurized Metered Dose Inhaler Product Specification
14.3.3 AstraZeneca Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Teva
14.4.1 Teva Company Profile
14.4.2 Teva Pressurized Metered Dose Inhaler Product Specification
14.4.3 Teva Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Merck & Co. Inc
14.5.1 Merck & Co. Inc Company Profile
14.5.2 Merck & Co. Inc Pressurized Metered Dose Inhaler Product Specification
14.5.3 Merck & Co. Inc Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Boehringer Ingelheim
14.6.1 Boehringer Ingelheim Company Profile
14.6.2 Boehringer Ingelheim Pressurized Metered Dose Inhaler Product Specification
14.6.3 Boehringer Ingelheim Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Mylan
14.7.1 Mylan Company Profile
14.7.2 Mylan Pressurized Metered Dose Inhaler Product Specification
14.7.3 Mylan Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Arkon
14.8.1 Arkon Company Profile
14.8.2 Arkon Pressurized Metered Dose Inhaler Product Specification
14.8.3 Arkon Pressurized Metered Dose Inhaler Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Pressurized Metered Dose Inhaler Market Forecast (2022-2027)
15.1 Global Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Pressurized Metered Dose Inhaler Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Pressurized Metered Dose Inhaler Value and Growth Rate Forecast (2022-2027)
15.2 Global Pressurized Metered Dose Inhaler Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Pressurized Metered Dose Inhaler Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Pressurized Metered Dose Inhaler Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Pressurized Metered Dose Inhaler Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Pressurized Metered Dose Inhaler Consumption Forecast by Type (2022-2027)
15.3.2 Global Pressurized Metered Dose Inhaler Revenue Forecast by Type (2022-2027)
15.3.3 Global Pressurized Metered Dose Inhaler Price Forecast by Type (2022-2027)
15.4 Global Pressurized Metered Dose Inhaler Consumption Volume Forecast by Application (2022-2027)
15.5 Pressurized Metered Dose Inhaler Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Related reports
Pharmaceutical Grade Sodium Chloride Market
$2850-$4575
Adenosine Triphosphate ATP Test Kit Market
$3300-$7000
Alpha 1 Antitrypsin Deficiency Treatment Market
$3300-$7000